We're excited to share our recent work in Nature Communications exploring prostate tumor heterogeneity at the single-cell level! Hats off to Nicholas Brady, Alyssa Bagadion and all of our collaborators who made this possible WCM Prostate SPORE Weill Cornell Medicine Pathology nature.com/articles/s4146…

Research suggests how tumors evolve to become an aggressive form of prostate cancer could lead to new treatments, in a study led by Dr. David Rickman of Weill Cornell Medicine Pathology and co-first authors Drs. Nicholas Brady and Alyssa Bagadion of Weill Cornell GSMS. bit.ly/3yaqrr8

Congrats to our very own Nicholas Brady !

It's a beautiful day Rockefeller University and we are ready for the Henry Kunkel Society Meeting! 🔬 Journal of Experimental Medicine editors will be here all day, let us know if you'd like to chat!

We’re hiring! (2x technicians and a post-doc) Are you interested in the molecular and epigenetic drivers of neuroendocrine prostate cancer development? Want to use novel GEMMs and organoid models? Look no further! Reach out to [email protected] for more information.

Congratulations to Dr. David Rickman who received a $3.2M grant from the National Cancer Institute for a study entitled “DNMT and TET1 reprogramming as a targetable mechanism of resistance in advanced prostate cancer.” Weill Department of Medicine National Cancer Institute

Congratulations to Dr. David Rickman (Rickman Lab), Associate Professor of #Pathology and Laboratory Medicine from Weill Cornell Medicine Pathology, on his new grant from National Cancer Institute to support #prostatecancer research! #PathTwitter

Congratulations to our 13 new Urology Care Foundation Research Scholar awardees! The UCF’s Research Scholar Awards support future research leaders and ensure they receive the necessary training and guidance for a successful research career. Learn more here ➡️ bit.ly/3TxtibH

Honoured to have received the 2023 Research Scholar Award. Thank you Amer. Urol. Assn. Society of Urologic Oncology Urology Care Foundation for supporting the research.

Congratulations Balaji! Our new paper Nature Communications highlights the context specific role of EZH2 in prostate cancer. Thank you to many collaborators Myles Brown Rickman Lab and funding support Prostate Cancer Foundation DF/HCC National Cancer Institute #SPORE rdcu.be/dQo0P Dana-Farber #BeltranLab